FDA Inspection 1224183 — Eurofins Amatsi Analytics
The FDA completed an inspection of Eurofins Amatsi Analytics on Nov 3, 2023 in Fontenilles. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fontenilles (France)
Additional details
Bioanalytical BA/BE